All News
FDA approves a next-generation Covid vaccine from Moderna, with restrictions
The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing Covid shot does not currently face.
Read MoreSTAT+: A top Merck executive sees a ‘fragile’ situation at NIH, but less cause for alarm over Chinese competition
Amid ongoing uncertainty around funding for the NIH and what it could mean for U.S. innovation, a top Merck executive stressed that the agency is “a fragile thing.
Read More‘Breakthrough’ breast cancer therapy can slow advance of disease and prolong survival
Study shows combination treatment for aggressive breast cancer delays advance by average 17 months and chemotherapy by two yearsA new triple therapy for aggressive, advanced breast cancer slows the pr
Read MoreChemo-Free Doublet in First-Line Boosts PFS in Triple-Negative Breast Cancer
(MedPage Today) -- CHICAGO -- Combining pembrolizumab (Keytruda) with sacituzumab govitecan (SG, Trodelvy) instead of chemotherapy as first-line treatment significantly reduced the risk of progress
Read MoreNovel Oral Agent for ESR1-Mutated Breast Cancer Boosts PFS in Second-Line
(MedPage Today) -- CHICAGO -- The investigational oral agent vepdegestrant more than doubled median progression-free survival (PFS) versus fulvestrant (Faslodex) in previously treated estrogen rece
Read MoreT-DXd Prevails in Trial of Second-Line Therapies for HER2 Gastroesophageal Cancer
(MedPage Today) -- CHICAGO -- Patients with progressive HER2-positive gastroesophageal (GE) cancer lived significantly longer when they received the antibody-drug conjugate (ADC) trastuzumab deruxt
Read MoreGene-Driven Adjuvant Therapy for NSCLC Leads to Big Improvement in DFS
(MedPage Today) -- CHICAGO -- Biomarker-driven adjuvant therapy for intermediate/high-risk non-small cell lung cancer (NSCLC) led to significantly longer disease-free survival (DFS) as compared wit
Read MoreSTAT+: Combination treatment reduces risk of tumor progression in aggressive form of breast cancer, study shows
The use of Gilead’s Trodelvy and Merck’s Keytruda together could be practice-changing based on the results of a new study presented at an ASCO meeting.
Read MoreJournalists Draw Link Between Internet Dead Zones, Threatened Medicaid Cuts, and Health
KFF Health News journalists made the rounds on national or local media recently to discuss topical stories. Here’s a collection of their appearances.
Read MoreVapers warned not to stockpile ‘fire risk’ disposables before UK ban
The ban, enforced from Sunday, is designed to reduce youth vaping and tackle environmental damageVapers have been warned not to stockpile soon-to-be-banned disposables before Sunday’s outright ban a
Read More